Top Markets
Coin of the day
Spago Nanomedical AB (publ) Spago Nanomedical AB (publ)

Spago Nanomedical AB (publ)

SPAGO
株式のランク #32285
Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to... Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to pioneering nanomedicines for both the diagnosis and treatment of cancer. The company is actively pursuing two key projects: the SpagoPix initiative, centered on SN132D, a gadolinium-free MRI contrast agent developed for imaging breast and pancreatic cancers; and the Tumorad project, which is advancing SN201, a radionuclide therapy intended for managing advanced and metastatic forms of cancer. Originally established as Spago Imaging AB (publ), the company adopted its current name, Spago Nanomedical AB (publ), in May 2014. Founded in 1999, its base of operations is situated in Lund, Sweden.
株価
$0.01317984
最終同期: 2026-08-17
時価総額
$10.52M
変化(1日)
-1.26%
変化(1年)
-53.51%
SE
取引 Spago Nanomedical AB (publ) (SPAGO)

カテゴリー

Spago Nanomedical AB (publ)(SPAGO)の配当利回りの履歴
Spago Nanomedical AB (publ)(銘柄コード: SPAGO)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Spago Nanomedical AB (publ)(SPAGO)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)